This determination was based on chronic toxicity studies, genotoxicity studies, and human clinical trial safety data
Iron metabolism regulatory drugs modulate the stability and localization of core ferroptosis proteins such as FPN1, FTH1, and TFR1 through PTMs including phosphorylation, ubiquitination, and acetylation, thereby rapidly reshaping the intracellular iron pool
Studies have shown significant declines in VAT, hepatic fat, and trunk-to-appendicular fat ratio with tesamorelin treatment
Although further clarification of the structure and mechanism related to the Na + -dependent glutathione transporter is needed, the synthetic skill and expertise in ligand identification, structure modification, and optimization of a medicinal chemist will undoubtedly facilitate the development of more diverse, potent, and effective glutathione transporter-based brain targeting ligands
Thymosin beta4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice
10.1001/jama.2019.11825 50